Know Cancer

or
forgot password

Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic Adenocarcinoma


N/A
18 Years
N/A
Open (Enrolling)
Both
Pancreatic Adenocarcinoma

Thank you

Trial Information

Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic Adenocarcinoma


Inclusion Criteria:



- Histological or cytological diagnosis of pancreatic adenocarcinoma, confirmed at
MSKCC.

- Patient eligible for chemotherapy treatment.

- Prior surgery, chemotherapy and/or radiation therapy for pancreatic adenocarcinoma is
permitted.

- ECOG performance status 0-2.

- A minimum age of 18 years old.

Exclusion Criteria:

- Known to be HIV positive on antiretroviral therapy

- Prior organ allograft

- Any medical or psychiatric condition that may interfere with the ability to comply
with protocol procedures

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

isolating and enriching circulating tumorigenic cells

Outcome Description:

A 10 mL blood sample will be drawn from participants prior to starting chemotherapy treatment. circulating tumorigenic cells from the peripheral blood of eligible pancreatic cancer patients. During the 1 year following enrollment, in the setting of disease progression, a subsequent 10 mL blood sample may be drawn from participants prior to changing chemotherapy treatment.

Outcome Time Frame:

1 year

Safety Issue:

No

Principal Investigator

Kenneth Yu, M.D., M.Sc.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

11-141

NCT ID:

NCT01474564

Start Date:

November 2011

Completion Date:

November 2013

Related Keywords:

  • Pancreatic Adenocarcinoma
  • Blood draw
  • pancreas
  • Tumorigenic Cells
  • 11-141
  • Adenocarcinoma
  • Adenocarcinoma, Mucinous

Name

Location

Memorial Sloan Kettering Cancer CenterNew York, New York  10021